What the designation actually covers
An RUO product is one supplied to a research buyer for laboratory work. The label carries no dosing directions, no route of administration, no therapeutic indication and no claim about what the compound does in a person. The marketing around it does the same.
Regulators assess the designation by looking at the whole picture: label text, website copy, social posts, customer service replies, packaging inserts, and who the buyers actually are. A vial that says “research use only” while the store page explains a weekly protocol is not an RUO product. It is an unapproved new drug with a disclaimer on it.
Where operators lose the designation
- Dosing language anywhere. A protocol, a milligram-per-week suggestion, a reconstitution calculator framed around body weight.
- Benefit claims. Describing what the compound does in a human body, in any tense.
- Selling to individuals for personal use. Consumer checkout with no research buyer qualification is the single clearest signal.
- Testimonials and before-and-after imagery. A customer review describing personal results is a claim the seller published.
Why it matters commercially, not just legally
Payment underwriters read the same signals regulators do. The fastest way to lose a merchant account in this category is to hold an RUO label while running consumer-facing claim copy, because the acquirer’s compliance scan finds the mismatch before any agency does.